Trial Profile

Clinical study of MP 2021

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 19 Dec 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs MP-2021 (Primary)
Indications Autoimmune disorders; Bone disorders
Focus Adverse reactions

Most Recent Events

04 Dec 2023 According to a MedPacto media release, the company plans to proceed with development with the goal of obtaining clinical trial approval (IND) or technology transfer for the follow-up phase 1 clinical trial of MP2021.
06 Sep 2023 New trial record
04 Sep 2023 According to a MedPacto media release, the company expects to apply for a related clinical trial plan (IND) in 2024.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com